Related Experiment Video
Updated: Oct 11, 2025

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer
Published on: March 6, 2018
Internet of things-based lifestyle intervention for prostate cancer patients on androgen deprivation therapy: a
Yong Hyun Park1,2,3,4,5,6,7, Jong In Lee2, Ji Youl Lee1
1Department of Urology, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea Seoul, Republic of Korea.
Abstract:
Androgen deprivation therapy (ADT) has several adverse effects including loss of libido, osteoporosis, and metabolic complications. We aim to examine whether the Smart After-Care (SAC) service, an Internet of Things (IoT)-based lifestyle intervention, affects clinical outcomes in prostate cancer (PCa) patients on ADT. A prospective, multicenter, randomized trial including 172 patients randomly assigned to the SAC or control group was conducted. The SAC group was provided with a smartphone application providing a personalized exercise program, daily activity monitoring, and diet counselling. The control group was briefly educated on the exercise program using a paper brochure. The primary endpoint was increase in cardiorespiratory endurance assessed using the 2-minute walking test (2MWT). Secondary endpoints included improved muscle strength (hand grip strength test and 30-second chair stand test), short physical performance battery, body composition, and health-related quality of life (EORTC-QLQ-C30 and PR25). Participants in both groups showed significant improvement in the 2MWT and 30-second chair stand test after 12 weeks of intervention. Greater improvement in the 2MWT was observed in the SAC group than in the control group. Significantly increased body fat ratio was observed in both groups; however, decreased skeletal muscle mass was observed only in the control group. Marginal improvement in skeletal muscle mass was observed over time in the SAC group when compared with that in the control group. Both groups showed improvement in all physical scales in the EORTC-QLQ-C30 questionnaire, and the SAC group showed a significant interaction of group and time for social functioning scales. SAC improved cardiorespiratory endurance, sarcopenic obesity, and health-related quality of life in patients with PCa on ADT.
Insights
Smart After-Care (SAC), an IoT-based lifestyle intervention, improved cardiorespiratory endurance and quality of life in prostate cancer patients undergoing androgen deprivation therapy (ADT). The SAC service demonstrated benefits over traditional methods for managing ADT side effects.
Area of Science:
- Oncology
- Digital Health
- Exercise Physiology
Background:
- Androgen deprivation therapy (ADT) for prostate cancer (PCa) is associated with adverse effects like loss of libido, osteoporosis, and metabolic complications.
- Effective management strategies are needed to mitigate these side effects and improve patient outcomes.
Purpose of the Study:
- To evaluate the impact of the Smart After-Care (SAC) service, an Internet of Things (IoT)-based lifestyle intervention, on clinical outcomes in PCa patients receiving ADT.
- To compare the efficacy of a digital lifestyle intervention against standard care for managing ADT-related side effects.
Main Methods:
- A prospective, multicenter, randomized trial involving 172 PCa patients on ADT.
- The intervention group received a smartphone app with personalized exercise, activity monitoring, and diet counseling (SAC group).
- The control group received standard education via a paper brochure. Primary endpoint: cardiorespiratory endurance (2-minute walking test). Secondary endpoints: muscle strength, physical performance, body composition, and quality of life.
Main Results:
- Both groups improved in the 2-minute walking test (2MWT) and 30-second chair stand test after 12 weeks.
- The SAC group showed significantly greater improvement in 2MWT compared to the control group.
- While both groups had increased body fat, only the control group experienced decreased skeletal muscle mass; the SAC group showed marginal muscle mass improvement.
Conclusions:
- The SAC service effectively improved cardiorespiratory endurance and health-related quality of life in PCa patients on ADT.
- SAC demonstrated a positive impact on mitigating sarcopenic obesity and enhancing social functioning compared to standard care.
- IoT-based lifestyle interventions represent a promising approach for comprehensive management of patients undergoing ADT.
More Related Videos
06:28E-Patient Counseling Trial E-PACO: Computer Based Education versus Nurse Counseling for Patients to Prepare for Colonoscopy
Published on: August 1, 2019
09:49Isolation of Adipose Derived Regenerative Cells for the Treatment of Erectile Dysfunction Following Radical Prostatectomy
Published on: December 28, 2021
Related Concept Videos
Treatment Resistant Cancers
Clinical Trials
There are four phases in a clinical trial. A phase one...
Clinical Trials: Overview
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Peripheral Artery Disease III: Interprofessional Care
Bioavailability Study Design: Healthy Subjects Versus Patients